Clinical Trial Update: Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluates the safety and pharmacokinetics of KBPA-101 for hospital-acquired pneumonia and ventilator-associated pneumonia caused by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• KBPA-101

Snippet

Sponsor: Kenta Biotech Ltd | Conditions: Pneumonia, Ventilator Associated Pneumonia | Phase 1, Phase 2 | Status: COMPLETED